These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 18989886

  • 1. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
    Luo XQ, Ke ZY, Huang LB, Guan XQ, Zhang YC, Zhang XL.
    Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
    [Abstract] [Full Text] [Related]

  • 2. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
    Jiang H, Gu LJ, Xue HL, Tang JY, Chen J, Pan C, Chen J, Xu C, Dong L, Zhou M.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology.
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [Abstract] [Full Text] [Related]

  • 4. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ, Ribera JM, Oriol A, Bastida P, González ME, Calvo C, Egurbide I, Hernández Rivas JM, Rivas C, Alcalá A, Besalduch J, Maciá J, Gardella S, Carnero M, Lite JM, Casanova F, Martinez M, Fontanillas M, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas.
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [Abstract] [Full Text] [Related]

  • 5. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R, Legitimo A, Rondelli R, Guguelmi C, Barisone E, Lippi A, Cantù-Rajnoldi A, Aricò M, Conter V, Cocito MG, Putti MC, Pession A, Masera G, Biondi A, Basso G.
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [Abstract] [Full Text] [Related]

  • 6. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, Ludwig WD, Riehm H, Schrappe M.
    Klin Padiatr; 2005 Nov; 217(6):310-20. PubMed ID: 16307416
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
    Nachman JB, Sather HN, Sensel MG, Trigg ME, Cherlow JM, Lukens JN, Wolff L, Uckun FM, Gaynon PS.
    N Engl J Med; 1998 Jun 04; 338(23):1663-71. PubMed ID: 9614257
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of childhood acute lymphoblastic leukemia treated in China.
    Tang Y, Xu X, Song H, Yang S, Shi S, Wei J.
    Pediatr Blood Cancer; 2008 Sep 04; 51(3):380-6. PubMed ID: 18506765
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
    Wang YR, Jin RM, Xu JW, Xiao Y, Zhou DF, Zhang ZQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb 04; 10(1):1-4. PubMed ID: 18289459
    [Abstract] [Full Text] [Related]

  • 11. The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China.
    Luo XQ, Ke ZY, Guan XQ, Zhang YC, Huang LB, Zhu J.
    Pediatr Blood Cancer; 2008 Aug 04; 51(2):204-9. PubMed ID: 18454471
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun 04; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C, Auclerc MF, Levy V, Porcher R, Piguet C, Perel Y, Gandemer V, Debre M, Vermylen C, Pautard B, Berger C, Schmitt C, Leblanc T, Cayuela JM, Socie G, Michel G, Leverger G, Baruchel A.
    J Clin Oncol; 2008 Mar 20; 26(9):1496-503. PubMed ID: 18349402
    [Abstract] [Full Text] [Related]

  • 16. Treatment outcome of adolescents with acute lymphoblastic leukemia.
    Irken G, Oren H, Gülen H, Duman M, Uçar C, Atabay B, Yilmaz S, Uysal K, Cevik N.
    Ann Hematol; 2002 Nov 20; 81(11):641-5. PubMed ID: 12454702
    [Abstract] [Full Text] [Related]

  • 17. Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial.
    Le QH, Thomas X, Ecochard R, Iwaz J, Lhéritier V, Michallet M, Fiere D.
    Cancer; 2007 May 15; 109(10):2058-67. PubMed ID: 17407135
    [Abstract] [Full Text] [Related]

  • 18. [Clinical importance of minimal residual disease testing in the therapy of childhood B-cell acute lymphoblastic leukemia].
    Ye QD, Gu LJ, Tang JY, Xue HL, Chen J, Pan C, Chen J, Dong L, Zhou M, Jiang LM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun 15; 10(3):333-6. PubMed ID: 18554462
    [Abstract] [Full Text] [Related]

  • 19. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, Kikuchi A, Takahashi H, Ikuta K, Hayashi Y, Hanada R, Tsuchida M, Tokyo Children's Cancer Study Group.
    Haematologica; 2008 Aug 15; 93(8):1155-60. PubMed ID: 18519521
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan Association of Childhood Leukemia Study.
    Horibe K, Hara J, Yagi K, Tawa A, Komada Y, Oda M, Nishimura S, Ishikawa Y, Kudoh T, Ueda K.
    Int J Hematol; 2000 Jul 15; 72(1):61-8. PubMed ID: 10979211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.